Literature DB >> 34375587

Clustered mutations in the GRIK2 kainate receptor subunit gene underlie diverse neurodevelopmental disorders.

Jacob R Stolz1, Kendall M Foote1, Hermine E Veenstra-Knol2, Rolph Pfundt3, Sanne W Ten Broeke2, Nicole de Leeuw3, Laura Roht4, Sander Pajusalu4, Reelika Part5, Ionella Rebane5, Katrin Õunap4, Zornitza Stark6, Edwin P Kirk7, John A Lawson8, Sebastian Lunke9, John Christodoulou6, Raymond J Louie10, R Curtis Rogers10, Jessica M Davis10, A Micheil Innes11, Xing-Chang Wei12, Boris Keren13, Cyril Mignot13, Robert Roger Lebel14, Steven M Sperber15, Ai Sakonju16, Nienke Dosa14, Daniela Q C M Barge-Schaapveld17, Cacha M P C D Peeters-Scholte18, Claudia A L Ruivenkamp17, Bregje W van Bon3, Joanna Kennedy19, Karen J Low19, Sian Ellard20, Lewis Pang20, Joseph J Junewick21, Paul R Mark22, Gemma L Carvill23, Geoffrey T Swanson24.   

Abstract

Kainate receptors (KARs) are glutamate-gated cation channels with diverse roles in the central nervous system. Bi-allelic loss of function of the KAR-encoding gene GRIK2 causes a nonsyndromic neurodevelopmental disorder (NDD) with intellectual disability and developmental delay as core features. The extent to which mono-allelic variants in GRIK2 also underlie NDDs is less understood because only a single individual has been reported previously. Here, we describe an additional eleven individuals with heterozygous de novo variants in GRIK2 causative for neurodevelopmental deficits that include intellectual disability. Five children harbored recurrent de novo variants (three encoding p.Thr660Lys and two p.Thr660Arg), and four children and one adult were homozygous for a previously reported variant (c.1969G>A [p.Ala657Thr]). Individuals with shared variants had some overlapping behavioral and neurological dysfunction, suggesting that the GRIK2 variants are likely pathogenic. Analogous mutations introduced into recombinant GluK2 KAR subunits at sites within the M3 transmembrane domain (encoding p.Ala657Thr, p.Thr660Lys, and p.Thr660Arg) and the M3-S2 linker domain (encoding p.Ile668Thr) had complex effects on functional properties and membrane localization of homomeric and heteromeric KARs. Both p.Thr660Lys and p.Thr660Arg mutant KARs exhibited markedly slowed gating kinetics, similar to p.Ala657Thr-containing receptors. Moreover, we observed emerging genotype-phenotype correlations, including the presence of severe epilepsy in individuals with the p.Thr660Lys variant and hypomyelination in individuals with either the p.Thr660Lys or p.Thr660Arg variant. Collectively, these results demonstrate that human GRIK2 variants predicted to alter channel function are causative for early childhood development disorders and further emphasize the importance of clarifying the role of KARs in early nervous system development.
Copyright © 2021 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GluK2; ataxia; channel gating; electrophysiology; epilepsy; glutamate receptor; intellectual disability; white matter abnormalities; whole-exome sequencing

Mesh:

Substances:

Year:  2021        PMID: 34375587      PMCID: PMC8456161          DOI: 10.1016/j.ajhg.2021.07.007

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  62 in total

1.  CRMP2 tethers kainate receptor activity to cytoskeleton dynamics during neuronal maturation.

Authors:  Joana M Marques; Ricardo J Rodrigues; Sergio Valbuena; Jose L Rozas; Sanja Selak; Philippe Marin; Maria I Aller; Juan Lerma
Journal:  J Neurosci       Date:  2013-11-13       Impact factor: 6.167

2.  Expanding the spectrum of Grik2 mutations: intellectual disability, behavioural disorder, epilepsy and dystonia.

Authors:  M Córdoba; S Rodriguez; D González Morón; N Medina; M A Kauffman
Journal:  Clin Genet       Date:  2014-07-10       Impact factor: 4.438

3.  A complex mosaic of high-affinity kainate receptors in rat brain.

Authors:  W Wisden; P H Seeburg
Journal:  J Neurosci       Date:  1993-08       Impact factor: 6.167

4.  Neurodegeneration in Lurcher mice caused by mutation in delta2 glutamate receptor gene.

Authors:  J Zuo; P L De Jager; K A Takahashi; W Jiang; D J Linden; N Heintz
Journal:  Nature       Date:  1997-08-21       Impact factor: 49.962

5.  The Lurcher mutation of an alpha-amino-3-hydroxy-5-methyl- 4-isoxazolepropionic acid receptor subunit enhances potency of glutamate and converts an antagonist to an agonist.

Authors:  F Taverna; Z G Xiong; L Brandes; J C Roder; M W Salter; J F MacDonald
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

6.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

7.  Endogenous activation of kainate receptors regulates glutamate release and network activity in the developing hippocampus.

Authors:  Sari E Lauri; Mikael Segerstråle; Aino Vesikansa; Francois Maingret; Christophe Mulle; Graham L Collingridge; John T R Isaac; Tomi Taira
Journal:  J Neurosci       Date:  2005-05-04       Impact factor: 6.167

8.  De novo mutations in GRIN1 cause extensive bilateral polymicrogyria.

Authors:  Andrew E Fry; Katherine A Fawcett; Nathanel Zelnik; Hongjie Yuan; Belinda A N Thompson; Lilach Shemer-Meiri; Thomas D Cushion; Hood Mugalaasi; David Sims; Neil Stoodley; Seo-Kyung Chung; Mark I Rees; Chirag V Patel; Louise A Brueton; Valérie Layet; Fabienne Giuliano; Michael P Kerr; Ehud Banne; Vardiella Meiner; Tally Lerman-Sagie; Katherine L Helbig; Laura H Kofman; Kristin M Knight; Wenjuan Chen; Varun Kannan; Chun Hu; Hirofumi Kusumoto; Jin Zhang; Sharon A Swanger; Gil H Shaulsky; Ghayda M Mirzaa; Alison M Muir; Heather C Mefford; William B Dobyns; Amanda B Mackenzie; Jonathan G L Mullins; Johannes R Lemke; Nadia Bahi-Buisson; Stephen F Traynelis; Heledd F Iago; Daniela T Pilz
Journal:  Brain       Date:  2018-03-01       Impact factor: 15.255

9.  Clinical application of whole-exome sequencing across clinical indications.

Authors:  Kyle Retterer; Jane Juusola; Megan T Cho; Patrik Vitazka; Francisca Millan; Federica Gibellini; Annette Vertino-Bell; Nizar Smaoui; Julie Neidich; Kristin G Monaghan; Dianalee McKnight; Renkui Bai; Sharon Suchy; Bethany Friedman; Jackie Tahiliani; Daniel Pineda-Alvarez; Gabriele Richard; Tracy Brandt; Eden Haverfield; Wendy K Chung; Sherri Bale
Journal:  Genet Med       Date:  2015-12-03       Impact factor: 8.822

10.  Kainate receptors regulate development of glutamatergic synaptic circuitry in the rodent amygdala.

Authors:  Maria Ryazantseva; Jonas Englund; Alexandra Shintyapina; Johanna Huupponen; Vasilii Shteinikov; Asla Pitkänen; Juha M Partanen; Sari E Lauri
Journal:  Elife       Date:  2020-03-23       Impact factor: 8.140

View more
  2 in total

1.  The antiseizure drug perampanel is a subunit-selective negative allosteric modulator of kainate receptors.

Authors:  Sakiko Taniguchi; Jacob R Stolz; Geoffrey T Swanson
Journal:  J Neurosci       Date:  2022-06-01       Impact factor: 6.709

2.  Genome-wide association study of the human brain functional connectome reveals strong vascular component underlying global network efficiency.

Authors:  Steven Bell; Daniel J Tozer; Hugh S Markus
Journal:  Sci Rep       Date:  2022-09-02       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.